Skip to main content

DLL3 Antibody (rovalpituzumab-MMAE) [Janelia Fluor® 635]

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28461JF635

Recombinant Monoclonal Antibody
Novus Biologicals, part of Bio-Techne

Key Product Details

Species Reactivity

Human

Applications

ELISA, Flow Cytometry, Functional

Label

Janelia Fluor 635

Antibody Source

Recombinant Monoclonal Human IgG1 Clone # rovalpituzumab-MMAE

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

DLL3

Clonality

Monoclonal

Host

Human

Isotype

IgG1

Applications for DLL3 Antibody (rovalpituzumab-MMAE) [Janelia Fluor® 635]

Application
Recommended Usage

ELISA

Optimal dilutions of this antibody should be experimentally determined.

Flow Cytometry

Optimal dilutions of this antibody should be experimentally determined.

Functional

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Protein A purified

Formulation

50mM Sodium Borate

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: DLL3

The DLL3 gene encodes a member of the delta protein ligand family. This family functions as Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. Mutations in this gene cause autosomal recessive spondylocostal dysostos

Long Name

Delta-like 3

Alternate Names

Pudgy, SCDO1

Gene Symbol

DLL3

Additional DLL3 Products

Product Documents for DLL3 Antibody (rovalpituzumab-MMAE) [Janelia Fluor® 635]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for DLL3 Antibody (rovalpituzumab-MMAE) [Janelia Fluor® 635]



Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...